Association between human leucocyte antigen subtypes and risk of end stage renal disease in Taiwanese: a retrospective study

BMC Nephrology

Chin-Chan Lee³  Marie Lin²  Chiao-Yin Sun⁴  Shin-Fan Chen⁴  Chen-Chung Chu¹  Ciou-Sia Dai⁴ 

[1] Department of Bioscience Technology, Chung Yuan Christian University, Chung-Li, Taiwan;Department of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan;Department of Nephrology, Chang Gung Memorial Hospital, Keelung, Taiwan;Department of Internal Medicine, Division of Nephrology, Chang Gung Memorial Hospital, Keelung, Taiwan

关键词: HLA types;    Chronic kidney disease;    Taiwan;    Human leukocyte antigen;    ESRD;   

Others  :  1231083
DOI  :  10.1186/s12882-015-0165-7

 received in 2015-01-08, accepted in 2015-10-14,  发布年份 2015

【 摘 要 】

Background

End stage renal disease (ESRD) is prevalent in Taiwan. Human leukocyte antigens (HLA) have been found to be associated with the pathogenesis of autoimmune diseases, allergies and inflammatory bowel diseases, and there are emerging evidences of correlations between HLA genotypes and renal diseases such as diabetic nephropathy, IgA nephropathy, and glomerulonephritis. The aim of this study is to investigate detailed HLA subtypes in a case-control study of Taiwanese individuals.

Methods

The polymorphisms of HLA class I and II antigens in ESRD patients and a healthy control group were retrospectively analyzed. The information of 141 ESRD patients was obtained from the medical record of the Keelung branch of Chang Gung Memorial Hospital and was compared to the HLA type of a control group comprized of 190 healthy unrelated Taiwanese from one of our previous studies. In order to standardize the HLA designation of prior low-resolution typings with the more advanced DNA based typings, all HLA-A, −B and -DR were analyzed using a low resolution serologic equivalent.

Results

The current work suggests that HLA-DR3 (odds ratio = 1.91, 95 % CI = 1.098–3.324, P = 0.024, Pc = 0.312) and HLA-DR11 (odds ratio = 2.06, 95 % CI = 1.133–3.761, P = 0.021, Pc = 0.273) may represent susceptibility risk factors for the development of ESRD in Taiwanese individuals. On the other hand, HLA-DR8 (odds ratio = 0.47, 95 % CI = 0.236–0.920, p = 0.027. Pc = 0.351) may be a protective factor. HLA-A and -B antigens did not show any contribution of progression to ESRD. However, we note that the significance of all these findings is lost when the results are corrected for multiple comparisons according to Bonferroni. Further investigation with a larger group of patients and control is needed to resolve this issue.

Conclusions

HLA typing might be a useful clinical method for screening patients with high risk of progression to ESRD.

【 授权许可】

   
2015 Dai et al.

【 参考文献 】

• [1]Kuo HW, Tsai SS, Tiao MM, Yang CY. Epidemiological features of CKD in Taiwan. Am J Kidney Dis : Off J National Kidney Foundation. 2007; 49(1):46-55.
• [2]Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology. 2010; 15 Suppl 2:3-9.
• [3]Wu IW, Hsu KH, Lee CC, Sun CY, Hsu HJ, Hung MJ, et al. Re-evaluating the predictive roles of metabolic complications and clinical outcome according to eGFR levels—a four-years prospective cohort study in Taiwan. BMC Nephrol. 2013;14.
• [4]Qaseem A, Hopkins RH, Sweet DE, Starkey M, Shekelle P. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2013; 159(12):835-847.
• [5]Parham P, Ohta T. Population biology of antigen presentation by MHC class I molecules. Science. 1996; 272(5258):67-74.
• [6]Marsh SG. Nomenclature for factors of the HLA system, update April 2010. Tissue Antigens. 2010; 76(6):501-508.
• [7]Lange CF. HL-A histocompatibility antigens and their relation to disease. Prog Clin Pathol. 1975; 6:137-162.
• [8]Tsao BP. An update on genetic studies of systemic lupus erythematosus. Curr Rheumatol Rep. 2002; 4(4):359-367.
• [9]Phillips EJ, Mallal SA. HLA and drug-induced toxicity. Curr Opin Mol Ther. 2009; 11(3):231-242.
• [10]Megiorni F, Pizzuti A. HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing. J Biomed Sci. 2012; 19:88. BioMed Central Full Text
• [11]van der Gaag R, Luyendijk L, Linssen A, Kijlstra A. Expression of HLA-B27 antigens on mononuclear leucocytes in ankylosing spondylitis. Clin Exp Immunol. 1985; 60(2):311-315.
• [12]Ahmad T, Marshall SE, Jewell D. Genetics of inflammatory bowel disease: the role of the HLA complex. WJG. 2006; 12(23):3628-3635.
• [13]Kallaur AP, Kaimen-Maciel DR, Morimoto HK, Watanabe MA, Georgeto SM, Reiche EM. Genetic polymorphisms associated with the development and clinical course of multiple sclerosis (review). Int J Mol Med. 2011; 28(4):467-479.
• [14]Kohara M, Naito S, Arakawa K, Miyata J, Chihara J, Taguchi T et al.. The strong association of HLA-DR4 with spherical mesangial dense deposits in IgA nephropathy. J Clin Lab Immunol. 1985; 18(4):157-160.
• [15]Dyck R, Bohm C, Klomp H. Increased frequency of HLA A2/DR4 and A2/DR8 haplotypes in young saskatchewan aboriginal people with diabetic end-stage renal disease. Am J Nephrol. 2003; 23(3):178-185.
• [16]Vuong MT, Lundberg S, Gunnarsson I, Wramner L, Lundstrom E, Fernstrom A et al.. Genetic evidence for involvement of adaptive immunity in the development of IgA nephropathy: MHC class II alleles are protective in a Caucasian population. Hum Immunol. 2013; 74(8):957-960.
• [17]Hsieh NK, Chu CC, Lee NS, Lee HL, Lin M. Association of HLA-DRB1*0405 with resistance to multibacillary leprosy in Taiwanese. Hum Immunol. 2010; 71(7):712-716.
• [18]Shaw CK, Chen LL, Lee A, Lee TD. Distribution of HLA gene and haplotype frequencies in Taiwan: a comparative study among Min-nan, Hakka, Aborigines and Mainland Chinese. Tissue Antigens. 1999; 53(1):51-64.
• [19]Lin M, Chu CC, Chang SL, Lee HL, Loo JH, Akaza T et al.. The origin of Minnan and Hakka, the so-called “Taiwanese”, inferred by HLA study. Tissue Antigens. 2001; 57(3):192-199.
• [20]Holdsworth R, Hurley CK, Marsh SG, Lau M, Noreen HJ, Kempenich JH et al.. The HLA dictionary 2008: a summary of HLA-A, −B, −C, −DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, −B, −C, −DR, and -DQ antigens. Tissue Antigens. 2009; 73(2):95-170.
• [21]van Dijk PC, Jager KJ, de Charro F, Collart F, Cornet R, Dekker FW et al.. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant: Off Pub Euro Dialysis Transplant Assoc - European Renal Assoc. 2001; 16(6):1120-1129.
• [22]Cao Q, Xie D, Liu J, Zou H, Zhang Y, Zhang H et al.. HLA polymorphism and susceptibility to end-stage renal disease in Cantonese patients awaiting kidney transplantation. PLoS One. 2014; 9(6): Article ID e90869
• [23]Rees AJ, Peters DK, Amos N, Welsh KI, Batchelor JR. The influence of HLA-linked genes on the severity of anti-GBM antibody-mediated nephritis. Kidney Int. 1984; 26(4):445-450.
• [24]Watts GF, Taub N, Gant V, Wilson I, Shaw KM. The immunogenetics of early nephropathy in insulin-dependent diabetes mellitus: association between the HLA-A2 antigen and albuminuria. Q J Med. 1992; 83(302):461-471.
• [25]Gerbase-DeLima M, Pereira-Santos A, Sesso R, Temin J, Aragao ES, Ajzen H et al.. Idiopathic focal segmental glomerulosclerosis and HLA antigens. Braz J Med Biol Res. 1998; 31(3):387-389.
• [26]Marchini M, Antonioli R, Lleo A, Barili M, Caronni M, Origgi L et al.. HLA class II antigens associated with lupus nephritis in Italian SLE patients. Hum Immunol. 2003; 64(4):462-468.
• [27]Park MH, Song EY, Ahn C, Oh KH, Yang J, Kang SJ et al.. Two subtypes of hepatitis B virus-associated glomerulonephritis are associated with different HLA-DR2 alleles in Koreans. Tissue Antigens. 2003; 62(6):505-511.
• [28]Vaglio A, Martorana D, Maggiore U, Grasselli C, Zanetti A, Pesci A et al.. HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum. 2007; 56(9):3159-3166.
• [29]Cordovado SK, Zhao Y, Warram JH, Gong H, Anderson KL, Hendrix MM et al.. Nephropathy in type 1 diabetes is diminished in carriers of HLA-DRB1*04: the genetics of kidneys in diabetes (GoKinD) study. Diabetes. 2008; 57(2):518-522.
• [30]Karahan GE, Seyhun Y, Oguz FS, Kekik C, Onal AE, Yazici H et al.. Impact of HLA on the underlying primary diseases in Turkish patients with end-stage renal disease. Ren Fail. 2009; 31(1):44-49.
• [31]Pan CF, Wu CJ, Chen HH, Dang CW, Chang FM, Liu HF et al.. Molecular analysis of HLA-DRB1 allelic associations with systemic lupus erythematous and lupus nephritis in Taiwan. Lupus. 2009; 18(8):698-704.
• [32]Yang R, Cui Z, Zhao J, Zhao MH. The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease. Clin Immunol. 2009; 133(2):245-250.
• [33]Chang DY, Luo H, Zhou XJ, Chen M, Zhao MH. Association of HLA genes with clinical outcomes of ANCA-associated vasculitis. CJASN. 2012; 7(8):1293-1299.
• [34]Perez-Luque E, Malacara JM, Olivo-Diaz A, Alaez C, Debaz H, Vazquez-Garcia M et al.. Contribution of HLA class II genes to end stage renal disease in mexican patients with type 2 diabetes mellitus. Hum Immunol. 2000; 61(10):1031-1038.
• [35]El-Gezawy EM, Baset HA, Nasif KA, Osama A, AbdelAzeem HG, Ali M et al.. Human leukocyte antigens as a risk factor for the primary diseases leading to end stage renal disease in Egyptian patients. Egypt J Immunol/ Egyptian Asso Immunologists. 2011; 18(2):13-21.
• [36]Doxiadis II, De Lange P, De Vries E, Persijn GG, Claas FH. Protective and susceptible HLA polymorphisms in IgA nephropathy patients with end-stage renal failure. Tissue Antigens. 2001; 57(4):344-347.
• [37]Tighe MR, Hall MA, Barbado M, Cardi E, Welsh KI, Ciclitira PJ. HLA class II alleles associated with celiac disease susceptibility in a southern European population. Tissue Antigens. 1992; 40(2):90-97.
• [38]Chou HT, Chen CH, Chen JY, Chang KC. Association of HLA DRB1-DQA1-DQB1 haplotypes with rheumatic heart disease in Taiwan. Int J Cardiol. 2008; 128(3):434-435.
• [39]Madeleine MM, Brumback B, Cushing-Haugen KL, Schwartz SM, Daling JR, Smith AG et al.. Human leukocyte antigen class II and cervical cancer risk: a population-based study. J Infect Dis. 2002; 186(11):1565-1574.
• [40]Yang J, Qiao HL, Zhang YW, Jia LJ, Tian X, Gao N. HLA-DRB genotype and specific IgE responses in patients with allergies to penicillins. Chin Med J. 2006; 119(6):458-466.
• [41]Hiki Y, Kobayashi Y, Tateno S, Sada M, Kashiwagi N. Strong association of HLA-DR4 with benign IgA nephropathy. Nephron. 1982; 32(3):222-226.
• [42]Mosaad YM, Mansour M, Al-Muzairai I, Al-Otabi T, Abdul-Moneam M, Al-Attiyah R et al.. Association between Human Leukocyte Antigens (HLA-A, −B, and -DR) and end-stage renal disease in Kuwaiti patients awaiting transplantation. Ren Fail. 2014; 36(8):1317-1321.
• [43]Almogren A, Shakoor Z, Hamam KD. Human leucocyte antigens: their association with end-stage renal disease in Saudi patients awaiting transplantation. Br J Biomed Sci. 2012; 69(4):159-163.
• [44]Freedman BI, Spray BJ, Heise ER. HLA associations in IgA nephropathy and focal and segmental glomerulosclerosis. Am J Kidney Dis : Off J National Kidney Foundation. 1994; 23(3):352-357.
• [45]Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am J Kidney Dis: Off J National Kidney Foundation. 1991; 18(1):12-19.
• [46]Berthoux FC, Genin C, Gagne A, Le Petit JC, Sabatier JC. HLA Bw35 antigen and mesangial IgA glomerulo-nephritis: a poor prognosis marker? Proc Euro Dialysis Transplant Assoc European Dialysis Transplant Assoc. 1979; 16:551-555.
• [47]Cao HX, Li M, Nie J, Wang W, Zhou SF, Yu XQ. Human leukocyte antigen DRB1 alleles predict risk and disease progression of immunoglobulin A nephropathy in Han Chinese. Am J Nephrol. 2008; 28(4):684-691.
• [48]Raguenes O, Mercier B, Cledes J, Whebe B, Ferec C. HLA class II typing and idiopathic IgA nephropathy (IgAN): DQB1*0301, a possible marker of unfavorable outcome. Tissue Antigens. 1995; 45(4):246-249.
• [49]Hiki Y, Kobayashi Y, Ookubo M, Obata F, Kashiwagi N. Association of HLA-DQw4 with IgA nephropathy in the Japanese population. Nephron. 1991; 58(1):109-111.
• [50]Chevrier D, Giral M, Perrichot R, Latinne D, Coville P, Muller JY et al.. Idiopathic and secondary membranous nephropathy and polymorphism at TAP1 and HLA-DMA loci. Tissue Antigens. 1997; 50(2):164-169.
• [51]Huang CC. Strong association of HLA-DR3 in Chinese patients with idiopathic membranous nephropathy. Tissue Antigens. 1989; 33(3):425-426.
• [52]Freedman BI, Spray BJ, Dunston GM, Heise ER. HLA associations in end-stage renal disease due to membranous glomerulonephritis: HLA-DR3 associations with progressive renal injury. Southeastern Organ Procurement Foundation. Am J Kidney Dis : Off J National Kidney Foundation. 1994; 23(6):797-802.
• [53]Reichert LJ, Koene RA, Wetzels JF. Prognostic factors in idiopathic membranous nephropathy. Am J Kidney Dis: Off J National Kidney Foundation. 1998; 31(1):1-11.
• [54]Bhimma R, Hammond MG, Coovadia HM, Adhikari M, Connolly CA. HLA class I and II in black children with hepatitis B virus-associated membranous nephropathy. Kidney Int. 2002; 61(4):1510-1515.
• [55]Haskell LP, Glicklich D, Senitzer D. HLA associations in heroin-associated nephropathy. Am J Kidney Dis: Off J National Kidney Foundation. 1988; 12(1):45-50.
• [56]Freedman BI, Espeland MA, Heise ER, Adams PL, Buckalew VM, Canzanello VJ. Racial differences in HLA antigen frequency and hypertensive renal failure. Am J Hypertens. 1991; 4(5 Pt 1):393-398.